8-K: Kimberly-Clark Q3 2025: Innovation Drives Organic Growth

Kimberly-Clark reports resilient third-quarter 2025 results with 2.5% organic sales growth driven by innovation and volume, while updating its full-year outlook.

Summary

• Net sales for Q3 2025 were $4.2 billion, in line with the prior year, with organic sales growth of 2.5% offset by divestitures and business exits.
• Adjusted gross margin for Q3 2025 was 36.8%, down 170 basis points versus the prior year, primarily due to unfavorable pricing net of cost inflation and incremental tariff-driven costs.
• Adjusted diluted earnings per share (EPS) attributable to Kimberly-Clark for Q3 2025 were $1.82, broadly in line with the prior year.
• Year-to-date sales decreased 2.6% to $12.4 billion, impacted by the PPE divestiture, private label diaper business exit, and foreign currency translation.
• Year-to-date organic sales grew 1.6%, driven by a 2.4% increase in volume, partially offset by 0.9% price investments.
• Year-to-date adjusted operating profit was $2.1 billion, a decline of 3.2% compared to $2.2 billion in 2024, including an 80 basis point unfavorable currency impact.
• Cash provided by operations year-to-date was $1.8 billion, down from $2.4 billion last year, driven by lower operating profit and working capital timing impacts.
• The company returned $1.4 billion to shareholders year-to-date through dividends and common stock repurchases.
• Total debt as of September 30, 2025, was $7.3 billion, down from $7.4 billion at December 31, 2024.

Sentiment

Score: 6

Explanation: The company shows resilience with strong organic sales and volume growth driven by innovation, and adjusted operating profit was in line with the prior year. However, adjusted gross margins declined, and reported EPS saw a significant drop due to transformation charges and tax impacts. The updated full-year outlook is modest, reflecting ongoing challenges in a dynamic operating environment, leading to a neutral-to-slightly positive sentiment.

Positives

• Organic sales grew 2.5% in Q3 2025, driven by 2.4% volume growth, reflecting strong innovation and activations.
• North America organic sales increased 2.7% in Q3, with volume growth of 2.6%.
• International Personal Care (IPC) organic sales increased 2.1% in Q3, with 2.0% volume growth and 1.6% enhanced portfolio mix.
• Personal Care categories in North America saw value market share up 30 basis points and volume share up 80 basis points year-to-date.
• IPC gained weighted share in Personal Care categories in Q3, with strong gains in Diapers and Pants.
• Q3 adjusted operating profit was in line with the prior year, benefiting from lower marketing, research, and general expenses due to efficiency gains and lower incentive accruals.
• Total debt decreased to $7.3 billion as of September 30, 2025, from $7.4 billion at December 31, 2024.

Negatives

• Adjusted gross margin for Q3 2025 was down 170 basis points versus the prior year, primarily due to unfavorable pricing net of cost inflation and incremental tariff-driven costs.
• Reported diluted EPS attributable to Kimberly-Clark for Q3 2025 was $1.34, down significantly from $2.69 in the prior year, impacted by transformation charges and tax matters.
• Year-to-date sales decreased 2.6% due to divestitures, business exits, and foreign currency translation.
• Year-to-date adjusted operating profit declined 3.2% compared to the prior year.
• Year-to-date adjusted EPS attributable to Kimberly-Clark decreased 2.2% to $5.67 from $5.80 last year, including currency translation headwinds of 160 basis points.
• Cash provided by operations year-to-date was $1.8 billion, a decrease from $2.4 billion last year.
• Capital spending increased to $741 million year-to-date, up from $512 million last year.
• Net interest expense increased to $59 million in Q3 from $49 million in the prior year, primarily due to lower interest income.
• The reported effective tax rate for Q3 was 45.4%, significantly higher than 19.4% in the prior year, due to transitory impacts from the One Big Beautiful Bill Act (OBBBA) and lapping of prior year tax matter resolutions.

Risks

• Risks related to delays or failure to complete the proposed IFP joint venture transaction with Suzano, including significant transaction and separation costs, adverse market reactions, regulatory or legal challenges, and operational disruptions.
• Risks of not realizing the anticipated benefits of the 2024 Transformation Initiative, including disruptions to business or operations or delays in implementation.
• Impacts from the war in Ukraine, including responses of consumers, customers, and suppliers, and sanctions.
• Government trade or similar regulatory actions, including current and potential trade and tariff actions affecting supply chain, commodity costs, and consumer spending.
• Pandemics and epidemics.
• Fluctuations in foreign currency exchange rates.
• Prices and availability of raw materials.
• Supply chain disruptions.
• Disruptions in the capital and credit markets.
• Counterparty defaults (customers, suppliers, financial institutions).
• Failure to realize expected benefits or synergies from acquisition and disposition activity.
• Impairment of goodwill and intangible assets.
• Changes in customer preferences.
• Severe weather conditions.
• Regional instabilities and hostilities, including the war in Israel.
• Potential competitive pressures on selling prices for products.
• Energy costs.
• General economic and political conditions globally and in the markets where the company does business.
• Ability to maintain key customer relationships.

Future Outlook

For 2025, organic sales growth is expected to be broadly in line with the weighted average growth in the categories and countries the company competes, currently estimated at approximately two percent. Reported net sales are forecast to have a negative impact of approximately 100 basis points from currency translation and a negative 290 basis point impact from divestitures and business exits. Adjusted operating profit is expected to grow at a low single-digit rate on a constant-currency basis, with negative impacts from divestitures, business exits, and currency translation. Adjusted earnings per share are projected to grow at a low-to-mid single-digit rate on a constant-currency basis, including a favorable impact of approximately 200 basis points ($0.16 per diluted share) from the cessation of depreciation and amortization expense for assets held for sale. Adjusted free cash flow is expected to be approximately $2 billion in 2025.

Management Comments

• "The operating environment remains dynamic, but we continue to execute our strategy with discipline and excellence as we play to win."
• "We once again delivered broad-based volume-plus-mix-led growth, even while volume has been somewhat challenged in the broader industry."
• "I'm very proud of how our teams around the world are living our purpose while also positioning Kimberly-Clark to drive value for our shareholders, customers, consumers, and our communities."

Industry Context

The company operates in a dynamic environment where volume growth has been somewhat challenged in the broader industry. Kimberly-Clark's focus on innovation-led volume growth and effective cost management has allowed it to maintain global weighted share and deliver resilient results, positioning itself as an industry-leading personal care company.

Comparison to Industry Standards

• Volume growth has been somewhat challenged in the broader industry, while Kimberly-Clark delivered broad-based volume-plus-mix-led growth.
• The company held global weighted share, reflecting the strength of its brands across geographies and its good-better-best product ladder.
• Kimberly-Clark is leveraging sustained, industry-leading productivity, although specific benchmarks or comparable companies are not detailed in the filing.

Stakeholder Impact

• Shareholders: Impacted by dividends, share repurchases, and the company's efforts to drive value, though reported EPS saw a significant decline.
• Customers/Consumers: Benefit from pioneering innovative new products and improved consumer value propositions across the portfolio.
• Employees: Affected by the 2024 Transformation Initiative aimed at creating a more agile and focused operating structure.
• Suppliers: Subject to supply chain disruptions and changes in raw material prices.
• Creditors: Total debt decreased, indicating a stable financial position.

Next Steps

• The IFP joint venture transaction with Suzano is anticipated to close mid-year 2026.

Key Dates

Recommendation

Kimberly-Clark demonstrated resilient organic sales growth and strong volume performance, driven by innovation, which is a positive indicator in a challenging market. The company is actively executing its 2024 Transformation Initiative and progressing with the IFP joint venture. However, the decline in adjusted gross margin, higher effective tax rate, and a significant drop in reported EPS, alongside a modest full-year outlook, suggest ongoing operational headwinds. While the company's brand strength and strategic actions provide a solid foundation, these challenges warrant a cautious stance. An investor should hold, monitoring the execution of the transformation, the successful completion of the IFP transaction, and the impact of cost inflation and tariffs on future margins.

Keywords

Kimberly-Clark, KMB, Q3 2025 Earnings, Consumer Goods, Personal Care, Organic Sales Growth, Financial Results, Outlook, Huggies, Kleenex, Corporate Transformation, SEC Filing